Synchronous papillary thyroid carcinoma and breast ductal carcinoma in 37 years old Iranian woman - A case report
-
Hedieh Moradi Tabriz
,
Arezoo Efekhar Javadi
,
Atieh Zandnejadi
,
Adel Yazdankhah kenary
,
Reza Hajebi
Abstract
Breast cancer is the most common cause of cancer death in women of middle age (20-59) through last decade. In contrast Incidence rates for thyroid cancer may have begun to stabilize in recent years. Synchronous neoplasms of both thyroid and breast cancer are very rare in clinic. The current study presents a case of synchronous papillary thyroid carcinoma and breast ductal carcinoma in 37 years old woman. It is proposed that the mechanism of these synchronous primary tumors is associated with an interaction between the breast and thyroid hormonal responses. It is important to examine breast tissue in patients with thyroid carcinoma or vice versa. In our case although axillary sentinel lymph node was free from tumor, cervical lymph nodes were involved by breast carcinoma; showing importance of cervical examination in breast cancer patients.
[1] Seigel R, Miller K, Jemal A: Cancer Statstcs 2018. CA: A Cancer Journal for Clinicians. 2018; 68(1):7-30. [DOI:10.3322/caac.21442] [PMID]
[2] Morris LG, Tutle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surgery. 2016; 142(7):709-11. [DOI:10.1001/jamaoto.2016.0230] [PMID] [PMCID]
[3] Bitorf B, Kessler H, Merkel S, Brückl W, Wein A, Ballhausen WG, et al. Multple primary malignancies: An epidemiological and pedigree analysis of 57 patents with at least three tumours. European Journal of Surgical Oncology. 2001; 27(3):302-13. [DOI:10.1053/ ejso.2001.1112] [PMID]
[4] Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Associaton Management Guidelines for adult patents with thyroid nodules and differentated thyroid cancer: The American Thyroid Associaton Guidelines task force on thyroid nodules and differentated thyroid cancer. Thyroid. 2016; 26(1):1-133. [DOI:10.1089/thy.2015.0020] [PMID] [PMCID]
[5] Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, VassilopoulouSellin R. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001; 92(2):225-31. [DOI:10.1002/1097- 0142(20010715)92:2<225::aid cncr1313>3.0.co;2-b] [PMID]
[6] Liu L, Shi J, Mao F, Wei J, Fu D, Zhang J. Synchronous primary cancers of the thyroid and breast: A case report and review of the literature. Oncology Leters. 2015; 9(1):351-4. [DOI:10.3892/ol.2014.2625]
[PMID] [PMCID]
[7] Wang C, Mayer JA, Mazumdar A, Brown PH. The rearranged during transfecton/Papillary Thyroid Carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positve breast cancer cells. Breast Cancer Research and Treatment. 2012; 133(2):487-500. [DOI:10.1007/s10549-011-1775-9] [PMID] [PMCID]
[8] Banzo J, Ubieto MA, González C, Razola P, Tardín L, Andrés A, et al. Papillary Thyroid Carcinoma synchronous with breast cancer: An incidental finding in an (18) F-FDG PET-CT study carried out in a search for occult
breast cancer. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2012; 31(4):213-5. [DOI:10.1016/j.remn.2011.11.009] [PMID]
[9] Zhong J, Lei J, Jiang K, Li Z, Gong R, Zhu J. Synchronous Papillary Thyroid Carcinoma and breast ductal carcinoma: A rare case report and literature review. Medicine (Baltmore). 2017; 96(7):e6114. [DOI:10.1097/MD.0000000000006114] [PMID] [PMCID]
[10] Garner CN, Ganetzky R, Brainard J, Hammel JP, Berber E, Siperstein AE, et al. Increased prevalence of breast cancer among patents with thyroid and parathyroid disease. Surgery. 2007; 142(6):806-13. [DOI:10.1016/j.surg.2007.07.024] [PMID]
[11] Van Fossen VL, Wilhelm SM, Eaton JL, McHenry CR. Associaton of thyroid, breast and renal cell cancer: A populaton-based study of the prevalence of second malignancies. Annals of Surgical Oncology. 2013; 20(4):1341-7. [DOI:10.1245/s10434-012-2718-3] [PMID]
[2] Morris LG, Tutle RM, Davies L. Changing trends in the incidence of thyroid cancer in the United States. JAMA Otolaryngol Head Neck Surgery. 2016; 142(7):709-11. [DOI:10.1001/jamaoto.2016.0230] [PMID] [PMCID]
[3] Bitorf B, Kessler H, Merkel S, Brückl W, Wein A, Ballhausen WG, et al. Multple primary malignancies: An epidemiological and pedigree analysis of 57 patents with at least three tumours. European Journal of Surgical Oncology. 2001; 27(3):302-13. [DOI:10.1053/ ejso.2001.1112] [PMID]
[4] Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, et al. 2015 American Thyroid Associaton Management Guidelines for adult patents with thyroid nodules and differentated thyroid cancer: The American Thyroid Associaton Guidelines task force on thyroid nodules and differentated thyroid cancer. Thyroid. 2016; 26(1):1-133. [DOI:10.1089/thy.2015.0020] [PMID] [PMCID]
[5] Chen AY, Levy L, Goepfert H, Brown BW, Spitz MR, VassilopoulouSellin R. The development of breast carcinoma in women with thyroid carcinoma. Cancer. 2001; 92(2):225-31. [DOI:10.1002/1097- 0142(20010715)92:2<225::aid cncr1313>3.0.co;2-b] [PMID]
[6] Liu L, Shi J, Mao F, Wei J, Fu D, Zhang J. Synchronous primary cancers of the thyroid and breast: A case report and review of the literature. Oncology Leters. 2015; 9(1):351-4. [DOI:10.3892/ol.2014.2625]
[PMID] [PMCID]
[7] Wang C, Mayer JA, Mazumdar A, Brown PH. The rearranged during transfecton/Papillary Thyroid Carcinoma tyrosine kinase is an estrogen-dependent gene required for the growth of estrogen receptor positve breast cancer cells. Breast Cancer Research and Treatment. 2012; 133(2):487-500. [DOI:10.1007/s10549-011-1775-9] [PMID] [PMCID]
[8] Banzo J, Ubieto MA, González C, Razola P, Tardín L, Andrés A, et al. Papillary Thyroid Carcinoma synchronous with breast cancer: An incidental finding in an (18) F-FDG PET-CT study carried out in a search for occult
breast cancer. Revista Espanola de Medicina Nuclear e Imagen Molecular. 2012; 31(4):213-5. [DOI:10.1016/j.remn.2011.11.009] [PMID]
[9] Zhong J, Lei J, Jiang K, Li Z, Gong R, Zhu J. Synchronous Papillary Thyroid Carcinoma and breast ductal carcinoma: A rare case report and literature review. Medicine (Baltmore). 2017; 96(7):e6114. [DOI:10.1097/MD.0000000000006114] [PMID] [PMCID]
[10] Garner CN, Ganetzky R, Brainard J, Hammel JP, Berber E, Siperstein AE, et al. Increased prevalence of breast cancer among patents with thyroid and parathyroid disease. Surgery. 2007; 142(6):806-13. [DOI:10.1016/j.surg.2007.07.024] [PMID]
[11] Van Fossen VL, Wilhelm SM, Eaton JL, McHenry CR. Associaton of thyroid, breast and renal cell cancer: A populaton-based study of the prevalence of second malignancies. Annals of Surgical Oncology. 2013; 20(4):1341-7. [DOI:10.1245/s10434-012-2718-3] [PMID]
| Files | ||
| Issue | Vol 6 No 1 (2021): January-February | |
| Section | Case Report(s) | |
| DOI | https://doi.org/10.18502/crcp.v6i1.5950 | |
| Keywords | ||
| breast ductal carcinoma papillary thyroid carcinoma | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
How to Cite
1.
Moradi Tabriz H, Efekhar Javadi A, Zandnejadi A, Yazdankhah kenary A, Hajebi R. Synchronous papillary thyroid carcinoma and breast ductal carcinoma in 37 years old Iranian woman - A case report. CRCP. 2021;6(1):1-5.
